That MTA could still not be detected in these contexts suggests that <1 μM MTA is present in GBM tumors, which supports our conclusion that there are no glioma tumors, regardless of MTAP deletion status, with extreme elevations in MTA. The gene discussed is MTAP; the disease is glioma.